India s drug regulator, the Central Drugs Standards Control Organisation (CDSCO) has approved the extension of shelf life of indigenously-developed Covid-19 vaccine Covaxin from nine to 12 months.The Hyderabad-based Bharat Biotech announced on .
The CDSCO had given its approval for extending the shelf life to nine months after Bharat Biotech submitted updated accelerated and real-time stability data of Covaxin, whihc is now further extended to 12 months from the date of manufacturing.
Delta Covid infection, which can progress to ICU admissions and death, can be stopped in its tracks by monoclonal antibody therapy, claims a new study.Developed by Swiss Drug major Roche, Casirivimab-Imdevimab injection is a cocktail of two .
Is antibody cocktail offering the right mix? biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.